Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Covance Inc. (NYSE:CVD)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
210 Carnegie Center
Princeton, NJ 08540
Phone: (609) 452-4440
Fax: (609) 452-4769
Email: investor.relations@covance.com
Employees (last reported count): 7,900
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 400 MidCap
Ownership
·Insider and 5%+ Owners: 24%
·Over the last 6 months:
 · 5 insider sells; 114.0K shares
  (0.8% of insider shares)
·Institutional: 75% (99% of float)
(361 institutions)
·Net Inst. Buying: 3.98M shares (+8.25%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Covance Inc. is a contract research organization providing product development services on a worldwide basis to the pharmaceutical, biotechnology and medical device industries. The Company also provides health economics and outcomes services for managed care organizations, hospitals and other healthcare providers, and laboratory testing services to the chemical, agrochemical and food industries. The services Covance provides constitute two segments for financial reporting purposes, early development services, which include preclinical and Phase I clinical service capabilities, and late-stage development services, which include clinical development, clinical support, biomanufacturing and commercialization services.
More from Market Guide: Expanded Business Description

Financial Summary
CVD is a contract research organization providing integrated product development services to biotechnology, pharmaceutical and medical device industries. For the six months ended 6/30/01, revenues increased 8% to $455.1 million. Net income totaled $29.1 million, up from $6.2 million. Revenues reflect strond demand for the Company's toxicology business. Net income reflects the inclusion of a $30.8 million gain on the sale of business.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Christopher Kuebler, 47
Chairman, Pres, CEO, Director
$1.2M
William Klitgaard, 47
CFO, Sr. VP, Treasurer
--  
Charles Harwood, Jr, 47
Sr. VP, Venture Devel.
--  
Joseph Herring, 45
Corp. Sr. VP and Pres, Early Devel. Services
708K
Alan Horgan, 44
Corp. Sr. VP and Pres, Clinincal Devel.
571K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:CVDAs of 31-Aug-2001
Price and Volume
52-Week Low
on 18-Oct-2000
$6.625
Recent Price$19.22 
52-Week High
on 19-July-2001
$25.50 
Beta0.73 
Daily Volume (3-month avg)539.1K
Daily Volume (10-day avg)608.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+83.0%
52-Week Change
relative to S&P500
+145.6%
Share-Related Items
Market Capitalization$1.13B
Shares Outstanding59.0M
Float44.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$5.18 
Earnings (ttm)$0.65 
Earnings (mrq)-$0.05 
Sales (ttm)$15.47 
Cash (mrq)$0.38 
Valuation Ratios
Price/Book (mrq)3.71 
Price/Earnings (ttm)29.66 
Price/Sales (ttm)1.24 
Income Statements
Sales (ttm)$901.4M
EBITDA (ttm)$103.9M
Income available to common (ttm)$38.1M
Profitability
Profit Margin (ttm)4.2%
Operating Margin (ttm)5.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)5.33%
Return on Equity (ttm)13.45%
Financial Strength
Current Ratio (mrq)1.56 
Debt/Equity (mrq)0.08 
Total Cash (mrq)$22.2M
Short Interest
As of 8-Aug-2001
Shares Short2.64M
Percent of Float5.9%
Shares Short
(Prior Month)
2.50M
Short Ratio4.38 
Daily Volume602.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.